Continuous monitoring of vital parameters for clinically valid assessment of human health status by Martins, Neusa Rebeca Adão
 2019 
UNIVERSIDADE DE LISBOA 
FACULDADE DE CIÊNCIAS 
DEPARTAMENTO DE FÍSICA 
 
 
 
 
 
 
Continuous Monitoring of Vital Parameters for Clinically Valid 
Assessment of Human Health Status 
 
 
 
 
Neusa Rebeca Adão Martins 
 
 
 
Mestrado Integrado em Engenharia Biomédica e Biofísica 
 Perfil Sinais e Imagens Médicas 
 
 
Dissertação orientada por: 
Dr. Alexandre Andrade 
Dr. Simon Annaheim 
 
 
 
 
 
 ii 
 
 
 
 
 
 
  
 iii 
 
Acknowledgments 
 
First, I would like to express my deepest gratitude to God, for all He is and has done for me. 
Many thanks to my family. Words cannot describe my thankfulness for your support, care and 
love throughout my academic journey. 
A special thanks to my supervisors, Alexandre Andrade and Simon Annaheim. Thank you very 
much for your support, guidance and constructive criticism during the entire process of producing this 
dissertation. 
I would also like to acknowledge the valuable contribution of Isabelle Gentgen, Claire Guignier, 
Dario, Martin Camenzind, Michel Schmid, Piero Fontana and Patrick Eggenberger, to this work. 
 
  
 iv 
 
Abstract  
 
The lack of devices suitable for acquiring accurate and reliable measures of patients' physiolog-
ical signals in a remote and continuous manner  together with the advances in data acquisition technol-
ogies during the last decades, have led to the emergence of wearable devices for healthcare. Wearable 
devices enable remote, continuous and long-term health monitoring in unattended setting. In this con-
text, the Swiss Federal Laboratories for Material Science and Technology (Empa) developed a wearable 
system for long-term electrocardiogram measurements, referred to as textile belt. It consists of a chest 
strap with two embroidered textile electrodes. The validity of Empa’s system for electrocardiogram 
monitoring has been proven in a clinical setting. This work aimed to assess the validity of the textile 
belt for electrocardiogram monitoring in a home setting and to supplement the existing system with 
sensors for respiratory monitoring. Another objective was to evaluate the suitability of the same weara-
ble, as a multi-sensor system, for activity monitoring. 
A study involving 12 patients (10 males and 2 females, interquartile range for age of 48–59 
years and for body mass indexes of 28.0–35.5 kg.m-2) with suspected sleep apnoea was carried out. 
Overnight electrocardiogram was measured in a total of 28 nights. The quality of recorded signals was 
assessed using signal-to-noise ratio, artefacts detection and Poincaré plots. Study data were compared 
to data from the same subjects, acquired in the clinical setting. For respiratory monitoring, optical fibre-
based sensors of different geometries were integrated into the textile belt. Signal processing algorithms 
for breathing rate and tidal volume estimation based on respiratory signals acquired by the sensors were 
developed. Pilot studies were conducted to compare the different approaches for respiratory monitoring. 
The quality of respiratory signals was determined based on signal segments “sinusoidality”, evaluated 
through the calculation of the cross-correlation between signal segments and segment-specific reference 
waves. A method for accelerometry-based lying position recognition was proposed, and the proof of 
concept of activity intensity classification through the combination of subjects’ inertial acceleration, 
heart rate and breathing rate data, was presented. Finally, a study with three participants (1 male and 2 
females, aged 21 ± 2 years, body mass index of 20.3 ± 1.5 kg.m-2) was conducted to assess the validity 
of the textile belt for respiratory and activity monitoring. 
Electrocardiogram signals acquired by the textile belt in the home setting were found to have 
better quality than the data acquired by the same device in the clinical setting. Although a higher artefact 
percentage was found for the textile belt, signal-to-noise ratio of electrocardiogram signals recorded by 
the textile belt in the home setting was similar to that of signals acquired by the gel electrodes in the 
clinical setting. A good agreement was found between the RR-intervals derived from signals recorded 
in home and clinical settings. Besides, for artefact percentages greater than 3%, visual assessment of 
Poincaré plots proved to be effective for the determination of the primary source of artefacts (noise or 
ectopic beats).  
Acceleration data allowed posture recognition (i.e. lying or standing/sitting, lying position) with 
an accuracy of 91% and positive predictive value of 80%. Lastly, preliminary results of physical activity 
intensity classification yielded high accuracy, showing the potential of the proposed method.  
The textile belt proved to be appropriate for long-term, remote and continuous monitoring of 
subjects’ physical and physiological parameters. It can monitor not only electrocardiogram, but also 
breathing rate, body posture and physical activity intensity, having the potential to be used as tool for 
disease prediction and diagnose support.  
 
 
 
Keywords: long-term electrocardiogram; respiratory monitoring; fibre optic sensing; activity 
monitoring; home monitoring. 
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Resumo  
 
Contexto: A falta de dispositivos adequados para a monitorização de sinais fisiológicos de um modo 
remoto e contínuo, juntamente com avanços tecnológicos na área de aquisição de dados nas últimas 
décadas, levaram ao surgimento de wearable devices, i.e. dispositivos vestíveis, no sector da saúde. 
Wearable devices possibilitam a monitorização do estado de saúde, de uma forma remota, contínua e de 
longa duração. Quando feito em ambiente domiciliar, este tipo de monitorização (i.e. contínua, remota 
e de longa duração) tem várias vantagens: diminui a pressão posta sobre o sistema de saúde, reduz 
despesas associadas ao internamento e acelera a resposta a emergências, permitindo deteção precoce e 
prevenção de condições crónicas. Neste contexto, a Empa, Laboratórios Federais Suíços de Ciência e 
Tecnologia de Materiais, desenvolveu um sistema vestível para a monitorização de eletrocardiograma 
de longa duração. Este sistema consiste num cinto peitoral com dois elétrodos têxteis integrados. Os 
elétrodos têxteis são feitos de fio de polietileno tereftalato revestido com prata e uma ultrafina camada 
de titânio no topo. De modo a garantir a aquisição de sinais de alta qualidade, o cinto tem nele integrado 
um reservatório de água que liberta vapor de água para humidificar os elétrodos. Este reservatório per-
mite a monitorização contínua de eletrocardiograma por 5 a 10 dias, sem necessitar de recarga. A vali-
dade do cinto para a monitorização de eletrocardiograma em ambiente clínico já foi provada. 
 
Objetivo: Este trabalho teve por objetivo avaliar a validade do cinto para a monitorização de eletrocar-
diograma em ambiente domiciliar e complementar o sistema existente com sensores para monitorização 
respiratória. Um outro objetivo foi analisar a adequação do cinto, como um sistema multisensor, para 
monitorização da atividade física. 
 
Métodos: Um estudo com 12 pacientes com suspeita de apneia do sono (10 homens e 2 mulheres, am-
plitude interquartil de 48–59 anos para a idade e de 28.0–35.5 kg.m-2 para o índice de massa corporal) 
foi conduzido para avaliar a qualidade do sinal de eletrocardiograma medido em ambiente domiciliar. 
O sinal de eletrocardiograma dos pacientes foi monitorizado continuamente, num total de 28 noites. A 
qualidade dos sinais adquiridos foi analisada através do cálculo da razão sinal-ruído; da deteção de ar-
tefactos, i.e., intervalos RR com um valor inviável de um ponto de vista fisiológico; e de gráficos de 
Poincaré, um método de análise não linear da distribuição dos intervalos RR registados. Os dados ad-
quiridos neste estudo foram comparados com dados dos mesmos pacientes, adquiridos em ambiente 
hospitalar.  
Para a monitorização respiratória, sensores feitos de fibra óptica foram integrados no cinto. Al-
gorítmicos para a estimar a frequência respiratória e o volume corrente dos sujeitos tendo por base o 
sinal medido pelas fibras ópticas foram desenvolvidos neste trabalho. As diferentes abordagens foram 
comparadas através de estudos piloto. Diferentes métodos para avaliação da qualidade do sinal adquirido 
foram sugeridos.  
Um método de reconhecimento da postura corporal através do cálculo de ângulos de orientação 
com base na aceleração medida foi proposto. A prova de conceito da determinação da intensidade da 
atividade física pela combinação de informações relativas á aceleração inercial e frequências cardíaca e 
respiratória dos sujeitos, é também apresentada neste trabalho. Um estudo foi conduzido para avaliar a 
validade do cinto para monitorização da respiração e da atividade física. O estudo contou com 10 parti-
cipantes, dos quais 3 vestiram o cinto para monitorização da respiração (1 homem e 2 mulheres, idade 
21 ± 2 anos, índice de massa corporal 20.3 ± 1.5 kg.m-2). 
 
Resultados: O estudo feito com pacientes com suspeita de apneia do sono revelou que os sinais eletro-
cardiográficos adquiridos pelo cinto em ambiente domiciliar foram de melhor qualidade que os sinais 
adquiridos pelo mesmo dispositivo em ambiente hospitalar. Uma percentagem de artefacto de 2.87% ± 
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4.14% foi observada para os dados adquiridos pelos elétrodos comummente usados em ambiente hospi-
talar, 7.49% ± 10.76% para os dados adquiridos pelo cinto em ambiente domiciliar e 9.66% ± 14.65% 
para os dados adquiridos pelo cinto em ambiente hospitalar. Embora tenham tido uma maior percenta-
gem de artefacto, a razão sinal-ruído dos sinais eletrocardiográficos adquiridos pelo cinto em ambiente 
domiciliar foi semelhante á dos sinais adquiridos pelos elétrodos de gel em ambiente hospitalar. Resul-
tados sugerem uma boa concordância entre os intervalos RR calculados com base nos eletrocardiogra-
mas registados em ambientes hospitalar e domiciliar. Além disso, para sinais com percentagem de arte-
facto superior a 3%, a avaliação visual dos gráficos de Poincaré provou ser um bom método para a 
determinação da fonte primária de artefactos (batimentos irregulares ou ruído).  
 A monitorização da aceleração dos sujeitos permitiu o reconhecimento da postura corporal (isto 
é, deitado ou sentado/em pé) com uma exatidão de 91% e valor preditivo positivo de 80%. Por fim, a 
classificação da intensidade da atividade física baseado na aceleração inercial e frequências cardíaca e 
respiratória revelou elevada exatidão, mostrando o potencial desta técnica. 
  
Conclusão: O cinto desenvolvido pela Empa provou ser apropriado para monitorização de longa-dura-
ção de variáveis físicas e fisiológicos, de uma forma remota e contínua. O cinto permite não só monito-
rizar eletrocardiograma, mas também frequência respiratória, postura corporal e intensidade da atividade 
física. Outros estudos devem ser conduzidos para corroborar os resultados e conclusões deste trabalho. 
Outros sensores poderão ser integrados no cinto de modo a possibilitar a monitorização de outras vari-
áveis fisiológicas de relevância clínica. Este sistema tem o potencial de ser usado como uma ferramenta 
para predição de doenças e apoio ao diagnóstico. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palavras-chave: eletrocardiograma de longa duração; monitorização da respiração; sensorização por 
fibra óptica; monitorização da atividade física; monitorização em casa.  
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1. INTRODUCTION 
 
1.1. Project scope and research plan  
The lack of devices suitable for acquiring accurate and reliable measures of patients' physiological 
signals in a remote and continuous manner together with the advances in data acquisition technologies 
during the last decades, has led to the emergence of wearable devices for healthcare. Within this field, 
the use of textile-based sensors is valuable as it enables unobtrusive and comfortable means of meas-
urement, while allowing long-term monitoring. 
Remote, continuous health monitoring in unattended setting has many advantages: decreases pres-
sure on health systems, reduces expenses associated with inpatient care and accelerates the response to 
emergencies while enabling early detection and prevention of chronic conditions. However, the lack of 
confidence in the quality of the signal acquired and its clinical relevance, the need to acquire and process 
large amount of data as well as the need to combine simplicity of use and robustness against artifacts 
while ensuring acceptable integration in user's daily life, data security and data privacy, are some of the 
main challenges within this field.  
Long-term health monitoring also requires systems with low power consumption and high energy 
efficiency and, when done by means of wearable sensors, the durability and signal integrity of the sen-
sors with time and cleaning process must be ensured. Most of the proposed systems consider only a 
specific physiological signal or parameter. However, the use of several wearable devices to monitor 
different physiological parameters is neither practical nor ergonomically sound; therefore, developing 
multi-sensor monitoring systems is desirable.  
With that knowledge in mind, the Swiss Federal Laboratories for Material Science and Technology 
(Empa) aim to develop a wearable monitoring system that enables continuous and non-invasive moni-
toring of multiple vital parameters, fulfilling accuracy requirements to be used in clinical settings. At 
this point, the system consists of a textile belt with integrated sensors combining own technologies, such 
as embroidered electrodes with Silver/Titanium coating for ECG monitoring [1] and optical fibre-based 
sensor for respiratory monitoring [2], with commercially available sensors, giving rise to the concept of 
"lab on the belt".  
The parameters of interest are respiratory rate; electrocardiogram (ECG) and RR-intervals based on 
the former; body posture, physical activity, movement patterns and energy expenditure; and, lastly, 
blood oxygen saturation (SpO2), since all these parameters can be measured from the skin surface. 
Respiratory rate, also called breathing rate, is one of the four classic vital signs, crucial to determine 
subjects' health status. It is used in the diagnosis of sepsis/ septic shock, sleep related breathing disorders, 
such as sleep apnea, and many other conditions. Likewise, ECG is essential in the diagnosis of cardio-
vascular diseases, the main cause of death globally according to the World Health Organization (WHO). 
Additionally, continuous ECG monitoring is used in intensive care unit (ICU) to monitor critically ill 
patients. Thus, due to their clinical relevance, these two parameters will be our focus of research. 
Furthermore, body posture and physical activity is taken into account, since it has been shown its 
suitability not only for fall detection in elderly care, but also for assistance of patients suffering from 
neurodegenerative disorders, motor diseases and cancer.  
Within this framework, this master thesis project intended to answer the following questions: 
1) How accurate is the ECG data recorded without supervision in home setting? 
2) Is it possible to accurately and continuously monitor breathing through the integration of optical 
fibre into the belt? 
a. If yes, is it possible to measure respiratory rate? 
b. And tidal volume? 
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3)  Is it possible to accurately recognize lying positions/ body postures/ activities/ activity patterns 
from accelerometry data? 
 
1.2. State of the art 
Devices currently used in clinical practice for the assessment of patients’ health status enable accu-
rate measurement of physiological parameters, yet they are not suitable for continuous ambulatory mon-
itoring. Even though continuous monitoring of vital signs, such as ECG and breathing rate, is applied to 
patients in ICUs, the vital signs of patients that are not in a critical condition are measured intermittently. 
However, patients’ health status may degrade in the time between measurements. Standard medical de-
vices used for diagnosis provide a “snapshot in time”[3] of patients’ health status. Nevertheless, relevant 
events may not occur during the examination, as might be the case in patients suffering from rare occur-
ring arrhythmias [4]; and the presence of a healthcare professional may induce changes in patients vital 
signs, as happens in white coat effect (i.e. increase in blood pressure associated with clinical visit [5]). 
Therefore, there is a need for medical devices enabling long-term, remote and continuous monitoring. 
The suitability of wearable devices for remote, continuous and long-term monitoring of physiolog-
ical parameters makes of such a technology the focus of study of many researchers, especially nowadays. 
Over the past decades, it has been observed a gradual increase in life expectancy worldwide simultane-
ously with declining birth rates. This phenomenon results in population aging, which requires a consid-
erable economic investment in order to provide the assistance needed to elderly, especially concerning 
healthcare [6].   
Wearable devices are any device a subject can “wear without encumbering daily activities or re-
stricting mobility” [3]. Sensors have been integrated in clothes (T-shirts, bras, socks, pants), watches, 
chest straps, elastic bands, patches, tags, glasses etc., ensuring continuous monitoring with the maximum 
wear comfort and minimum interference in subjects’ daily activities [3]. There is a wide range of appli-
cation fields of wearable devices [3], [6]–[9]: 
 
▪ Healthcare: monitoring for disease prediction, anomaly detection, recovery, rehabilitation, 
diagnosis support; 
▪ Assistive living; 
▪ Surveillance and security: monitoring of subjects in risky situations (e.g. solders, firefight-
ers or astronauts); 
▪ Fitness/Sport: monitoring of physical and physiological parameters to improve performance 
or increase wellness; 
▪ Human computer interaction and robotics. 
 
To be used in healthcare, wearable devices must satisfy various medical and ergonomic require-
ments. They must be of small dimension, comfortable, its components should be flexible, chemically 
inert, nontoxic, and hypoallergenic to the human body. For the successful commercialization, it should 
also be low-cost, lightweight, user-friendly, unobtrusive (should not require the user to wear many sen-
sors), non-invasive and, additionally, the whole system should not require user interaction too often [6], 
[8], [9]. 
Depending on their application, wearable devices can be used to monitor healthy subjects and pa-
tients, in home or clinical environment. Data can be stored locally on the wearable device (in the data-
logger unit) or be transmitted, via Bluetooth, Wi-Fi, ZigBee or long range radio, to receiving devices 
where it is displayed in real-time, or even to a remote monitoring center. While offline monitoring is 
adequate for disease prediction and diagnose support, it is not appropriate for activity monitoring or 
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anomaly detection (e.g. fall, seizure, or cardiac arrest detection), as both require real-time feedback (e.g. 
alarms) to medical staff and wearer [3], [10].  
The monitored bio signals and physiological parameters include ECG, heart rate (HR), electroen-
cephalogram, electromyogram, gait patterns, minute ventilation, breathing rate, breathing pattern, air 
quality, physical activity, arterial oxygen saturation, blood pressure, blood glucose, skin perspiration, 
galvanic skin response, capnography and  body temperature [3], [6], [10], [11]. The sensor most widely 
used in wearable devices is the accelerometer [11].  
A huge number of wearable devices are available on the market; however, the reliability, accuracy, 
safety and efficacy of the vast majority has not been proved. In fact, only an extremely reduced fraction 
of existing wearable devices are CE (Conformité Européenne) or  FDA (Food and Drug Administration) 
approved [3]. CE [12] and FDA [13] definitions of medical devices clearly include wearable devices for 
healthcare applications. Thus, most commercially available wearable devices cannot be commercialized 
as medical devices, as they do not have a mark of conformity. 
Wearable devices market has been constantly growing, being estimated that its total worth is over 
$50 billion this year [14]. Wearables for lifestyle, fitness and sport applications are predominant in this 
market. The market of wearable devices for healthcare applications is also growing, however, the lack 
of confidence in the quality of the acquired signal on the part of clinicians as well as the requirements 
in terms of device certification have been hindering its growth [10], [11].  
A summary on the standard devices as well wearable devices used for ECG, breathing and physical 
activity monitoring is presented in the following sections. 
 
1.2.1. ECG monitoring  
The surface ECG is a continuous record of voltage changes, generated as a response of cardiac 
muscles to electrical impulses generated by pacemaker cells [15]. In this way, the ECG reflects the 
cyclic electro-physiologic events in the myocardium, revealing the condition of heart’s electrical func-
tion [16].  It has a preponderant role in detection of heart defects and cardiac diseases such as auricular 
or ventricular hypertrophy, myocardial infarction (heart attack), arrhythmias and pericarditis. It also 
allows the analysis of heart rate variability (HRV), a straightforward way to study the autonomic nervous 
system activity. ECG signals are acquired by means of electrodes. 
Today’s gold standard for ECG recording are the gel electrodes. However, these electrodes have a 
limited application period, i.e. one or maximum two days, since they tend to run dry as the moisture 
content evaporates, and cause skin irritations on long-term use, apart from being uncomfortable for users 
[1], [17].  
Generally, biopotential electrodes can be categorized in three groups: wet, dry and non-contact elec-
trodes. Wet electrodes are the most common type, being the gold standard for clinical applications. Gel 
electrodes belong to this class. They consist of a metal (e.g. silver or gold) surrounded by a wet or solid 
hydrogel that is coupled to the skin (galvanic coupling). Dry electrodes operate without the use of an 
explicit moisturizing substance. Instead, the metal in the electrode directly contacts the skin using only 
some degree of moisture coming from the environment or emitted from the body (e.g. sweat). Their 
performance usually increases over time with increasing moisture between the electrode and the skin, 
as it reduces the electrode-skin impedance. There are also dry contact electrodes with capacitive cou-
pling, in which a thin dielectric layer is used to form an insulated contact with the body. Such electrodes 
measure electric surface potentials on the skin by the principle of electrostatic induction. The non-con-
tact electrodes are a particular case of dry electrodes. They function without being in direct contact with 
skin. Non-contact electrodes enable data acquisition through an insulation layer such as clothing [17].  
Although dry electrodes enable long-term ECG monitoring, to be used for clinical purposes their per-
formance must match that of gel electrodes.  
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Textile electrodes, made from textile fibers with conductive properties, have also been used as an 
alternative to gel electrodes.  They are flexible, adjusting easily to body topography, and can be unob-
trusively integrated into a garment. Additionally, air and moisture can pass through the porous textile 
electrodes, decreasing the risk for skin inflammation and increasing users’ comfort. However, data ac-
quired by textile electrodes is more susceptible to motion artefacts as electrodes can easily move relative 
to the skin. Ensuring electrodes integrity and durability as well as cope with the electric performance 
variation of such electrodes are among the greatest challenges in the field of textile electrodes for ECG 
monitoring [18]. 
The most popular device for long-term, ambulatory monitoring of ECG is the HolterTM ECG Re-
corder. It is a 12-lead wearable device that allows remote and continuous ECG monitoring up to 3 days 
[11], [19]. However, Holter monitors use conventional gel electrodes. Efforts have been made to develop 
wearable systems using different types of electrodes and with fewer leads, thus increasing comfort and 
unobtrusiveness, while increasing the monitoring time. Several wearable systems for long-term ECG 
monitoring, mainly chest straps, t-shirts and adhesive patches [10], have been proposed.  
 Table 1.1 presents some of the existing wearable devices for ECG monitoring. From the systems 
presented, the first four are commercially available, while the other four were proposed in literature. 
Zio, developed by iRhythm, is a patch able to monitor ECG for up to two weeks. Nuubo is a chest strap 
with integrated textile electrodes for long-term ECG-monitoring. Both are currently in use for clinical 
applications. Zoll LifeVest is a wearable cardioverter defibrillator that monitors ECG. It has been used 
to monitor patients at risk of sudden cardiac death.  
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Table 1.1. Wearable devices for remote, continuous and long-term ECG monitoring. CF: compact flash; LE: low energy; GMS: 
Global System for Mobile communications; ANT: Adaptive Network Topology. 
System/  
Proposition 
Number of 
electrodes 
Electrode 
type 
Sensors 
Placement 
Battery Life Connectivity 
Market 
Clearance 
Holter Recorder 
[19] 
12 
Wet  
electrodes 
Ventral 
Trunk 
3 days CF card 
FDA and 
CE 
Zio Patch [20] 2 
Hydrogel 
electrodes 
Chest 14 days Wireless FDA 
Zoll LifeVest 
[21] 
2 
Dry  
electrodes 
Chest 1 day Wireless FDA 
Nuubo [22] 2 
Textile  
electrodes 
Chest 5 days 
Wireless 
(Bluetooth LE) 
FDA and 
CE 
Sensorized T-
shirt and textile 
belt [23] 
3 
Dry textile 
electrodes 
Chest - 
Wireless 
(Bluetooth LE) 
- 
Wearable mo-
bile electrocar-
diogram moni-
toring system 
[24] 
3 
Dry foam 
electrodes 
Chest - 
Wireless 
(Bluetooth and 
GSM) 
- 
Wireless, porta-
ble capacitive 
ECG sensor 
[25] 
3 
Capacitive 
electrodes 
with cotton 
insulator 
Ventral 
Trunk 
- 
Wireless (ANT 
protocol) 
- 
Flexible capaci-
tive electrodes 
for reducing 
motion artifacts 
[26] 
2 
Flexible  
capacitive 
electrodes 
Chest - 
Wireless 
(Bluetooth) 
- 
 
 
1.2.1.1. Textile Belt for Long-Term ECG monitoring 
Empa developed a system for long-term ECG measurements. It consists of a textile belt (Unico 
Swiss Tex GmbH, Alpnachstad, Switzerland) with two embroidered textile electrodes from polyeth-
ylene terephthalate yarn, which are plasma coated with silver and with an ultra-thin titanium layer on 
top. The belt has stretchable parts and trims to ensure good electrode-skin contact for different body 
sizes, as shown in Figure 1.1. 
Since it was proved that humidification improves the signal quality in motion, electrodes are mois-
turized with a very low amount of water vapor from an integrated reservoir [1]. The integrated reservoir 
is composed of a wetting pad made from polyester that is impermeable to liquid water but allows the 
passage of water vapor. The wetting pad is connected to a flexible water tank and releases a small amount 
of water that evaporates mainly due to body heat of the wearer. The water vapor permeates the mem-
branes of the wetting pad thus creating a favorable silver-titanium-water electrode chemistry due to a 
high relative humidity atmosphere. This atmosphere prevents artifacts that results from the friction be-
tween electrode and skin, allowing the acquisition of good quality signal with baseline stability even 
when there are large body motions during the measurement. The water reservoir allows continuous ECG 
recording over 5-10 days without a refill. 
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Figure 1.1. Textile belt connected to data logger (red device). Front (top) and back (bottom) view. 
 
Electrodes measures are stored in a data logger. The validity, reliability and clinical relevance of 
this system are being tested by means of experiments with volunteers and clinical trials [27], [28]. 
 
1.2.2. Respiratory Monitoring 
At present, respiratory rate monitoring is done in a continuous manner only in ICUs. On general 
hospital wards, nurses measure it intermittently only. They do it manually, counting the number of 
breaths, based on patient's chest movement, during a minute. Apart of being a time-consuming task, it 
is hard to apply this methodology to non-cooperative patients. Consequently, breathing rate is the most 
neglected vital sign and its value is sometimes simply estimated or even guessed [29], [30]. 
Respiratory rate is an early indicator of patient's health status deterioration since the compensatory 
mechanisms normally first increase heart and respiratory rates. It is valuable to recognize acute changes 
in patients' condition, especially when measured in a continuous manner, as patient's health status can 
drastically change in the gaps between measurements when an intermittent methodology is followed. 
Respiratory rate increases in hypovolemia and increased respiratory rate can be an early marker of aci-
dosis. Additionally, abnormal respiratory rate is common prior to cardiac arrest [29].  Measuring tidal 
volume is also important when it comes to respiratory monitoring. Tidal volume is the volume of air 
that is inhaled and exhaled with each breath. Abnormalities in its value are related with asthma, pneu-
monia and chronic obstructive pulmonary disease.  
Respiratory rate and tidal volume are calculated from the respiratory signal acquired through differ-
ent techniques. The clinical standard techniques for respiratory monitoring include capnography, spi-
rometry, impedance pneumography, and respiratory inductive plethysmography (RIP). Capnography, 
also called end-tidal CO2 monitoring, is the standard for respiratory monitoring in ICUs and in the op-
erating room. It is the measurement of CO2 concentration in exhaled air over time [31]. Spirometry is 
the gold standard for tidal volume measurement [32]. Even though it is an accurate method, it is also 
invasive. During spirometry, the patient must breathe through a tube while wearing a nose clip or a face 
mask. Thus, such device is not suitable for continuous monitoring. It is uncomfortable and alters pa-
tient’s natural breathing behaviors.  
Impedance pneumography consists in measuring changes in transthoracic impedance as a function 
of respired volume using superficial thoracic electrodes [33], [34]. Pairs of electrodes (usually one or 
two [35]), one injecting current and other measuring voltage changes, are placed on the subject’s thorax 
to measure its impedance. Research has been conducted to find the optimal electrodes configuration, 
increasing accuracy and reducing obtrusiveness [36]. It is the clinical standard for electronic breathing 
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rate measurement [37].  It has been used during overnight polysomnography (PSG), the gold standard 
for the diagnosis of sleep related disorders [38], to monitor respiratory effort.  
RIP enables non-invasive respiratory monitoring by measuring the movement of the chest and ab-
dominal wall. Two inductance sensors (coils) integrated into elastic bands, one placed at the level of 
nipples and other at the level of umbilicus, are deployed to monitor respiratory movements.  Respiratory 
movements cause changes on the surface encircled by the sensors, altering the current induced by mag-
netic field in the coils [39], [40]. Output signal must be calibrated to measure volume. RIP devices are 
standard in clinical environment. Due to their portability, ambulatory RIP has been proposed [39][41], 
however body posture changes invalidate calibration. Thus, for volume measurement, recalibration is 
required each time subjects’ body position changes.  Brüllmann et al.[40] proposed an accelerometry-
based approach to solve the recalibration problem. Another study suggest that ambulatory RIP is a reli-
able method for respiratory monitoring [42].  
A review on the existing contact methods for measuring respiratory rate is presented in by Massaroni 
et al. [35]. They categorized the sensing principles for respiratory monitoring in seven groups: 
1) Respiratory airflow: measurement of the volume or velocity of inhaled and exhaled air using 
flowmeters. This method enables accurate breathing rate estimation but is intrusive, as usu-
ally implies use of face mask. 
2) Respiratory sounds: recording of respiratory sounds using microphones. This approach en-
ables monitoring with reduced encumbrance, being suitable to be applied in wearable de-
vices. However, its use is not recommended as microphones can easily record sounds that 
are not related to breathing. 
3) Air temperature: measurement of the difference between the temperature of inhaled and 
exhaled air, as inhaled air is at ambient temperature, while exhaled air is warmer. Thermis-
tors, thermocouples, pyroelectric sensors and optical fibres have been used for this purpose. 
This approach is sensitive to environmental factors, intrusive and not suitable for ambula-
tory monitoring. 
4) Air humidity: measurements of the water vapor content of inhaled and exhaled air, as ex-
haled air has higher humidity. Capacitive and resistive sensors are often used for humidity 
measurements. Optical fibres have also been employed. Although this approach is robust 
against motion artefacts, it is invasive and may require the use of a face mask. Air humidity 
sensors have been used in ICUs. 
5) Air components: measurement of level of carbon dioxide in inhaled (0.04%) and exhaled 
(6%) air, termed capnography, using infrared sensors and fiber optic sensors. It is an accu-
rate technique but also intrusive due to the high number of cables and connections. Capno-
graphy enables continuous monitoring of respiratory, however usually requires use of face 
mask. This is the approach commonly used in ICUs.  
6) Chest wall movements: respiratory monitoring based on the recording of respiratory mus-
cles movement. Strain sensors (i.e. resistive, capacitive, inductive and fiber optic sensors) 
have been used for detection of chest wall movements. Additionally, transthoracic imped-
ance sensors and movement sensors (i.e. accelerometers, gyroscopes and magnetometers) 
have also been deployed. Those sensors enable continuous recording of respiratory wave-
forms, being easily integrated into clothes and garments. This technique is unobtrusive, 
however, sensitive to motion artefacts. 
7) Modulation cardiac activity: extraction of respiratory signal from ECG or photoplethys-
mography (PPG), based on the respiratory modulation of cardiac signals.  The main ad-
vantage of this approach is that ECG and PPG sensors are already in use in clinical and 
home settings. This method is unobtrusive, but sensitive to motion artefacts. 
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Respiratory monitoring through non-contact methods have also been proposed [32], [43]. 
As the reader may notice, fiber optic sensors (FOSs) have been widely explored for respiratory 
monitoring purposes. Due to their good metrological properties, small size, flexibility and immunity 
from electromagnetic field, they are suitable to monitor patients remote and continuously, even in mag-
netic resonance imaging (MRI) environments, where standard electronic sensors cannot be deployed 
[44]. 
In FOSs, the optical fibre can be the sensing element (intrinsic sensors) or it can simply be used as 
a medium to transport light (extrinsic). There are two main types of FOSs employed in smart textiles for 
health monitoring: Fiber Bragg grating (FBG) technology based and intensity-based sensors [44]. Fun-
damentally, FBG sensors are a short segment of fiber optic, with usually 3 mm to 6 mm, which reflects 
a narrow range of wavelengths of the input light and transmits all the others due to exposure of the fibre 
core to an intense optical interference pattern. The wavelength range in which light is reflected is sensi-
tive to temperature and strain. Thus, those sensors enable temperature and strain estimation. They have 
been used to monitor stroke volume, blood pressure, heartbeats as well as respiration. Similar to FBG, 
long period granting (LPG) sensors enable measurement of several parameters. LPG “consists of a pe-
riodic change in the refractive index profile along the fiber” [45]. Characteristics of the attenuation bands 
enable the measurement of strain, bending, load and temperature.  
On the other hand, the working principle of intensity-based sensors is that the intensity of the light 
emitted by one fibre and conveyed into other fibre in close proximity to the first, is an indirect measure 
of the distance between the two fibres, and consequently of other parameters that influence this distance. 
A subtype of these group, macro-bending sensors, are based on the loss of light when the optical fibre 
is bent. Different bent radius result in different intensity modulations of the light transmitted by the fiber. 
Intensity-based sensors are used to monitor pressure and temperature. They have been proposed to meas-
ure intravascular and intracranial pressure. Macro-bending FOSs are mainly applied in respiratory 
movement monitoring. Table 1.2 presents some examples of sensors for respiratory monitoring based 
on optical fibres. Other approaches are presented in [44]. 
The sensor proposed by Krehel et al. [2] was developed by Empa researchers. They developed an 
optical fibre-based sensor that measures force or pressure applied to the sensor based on the light loss 
induced by changes in wave guiding properties due to changes in fibre’s geometry [44].  
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Table 1.2. Optical fibre-based sensors for respiratory monitoring. MRI: magnetic resonance imaging. 
System/ Proposition Sensor 
Working 
Principle 
Number of 
sensors 
Sensor 
Placement 
Features 
An Optical Fibre-Based 
Sensor [2] 
Intensity 
modulated 
FOS 
Respiratory 
movements 
1 Torso Non-invasive 
Smart textile embedding 
Optical fibre sensors [46] 
FBG FOS, 
Macro-bend-
ing FOS 
Respiratory 
movements 
2 
Thorax, 
Abdomen 
Non-invasive, 
MRI compatible 
Respiratory Sensors Using 
Plastic Optical Fiber [47] 
Intensity 
modulated 
FOS 
Airflow, 
Respiratory 
movements 
2 
Nose, 
Abdomen 
Non-invasive, 
MRI compatible 
Respiratory function 
monitoring using a real-time 
three-dimensional 
fiber-optic shaping sensing 
scheme based upon fiber 
Bragg gratings [48] 
FBG FOS 
Respiratory 
movements 
40 
Thorax, 
Abdomen 
Non-invasive 
Respiratory monitoring us-
ing long-period fiber grating 
sensors [45] 
LPG FOS 
Bending of 
the chest 
1 Chest Non-invasive 
 
Several commercially available wearable systems include sensors for respiratory monitoring. Some 
examples are shown in Table 1.3. The vast majority monitors breathing rate based on respiratory move-
ments as this is the working principle more appropriate for data acquisition outside clinical setting [35].  
 
Table 1.3. Wearable devices for remote, continuous and long-term respiratory monitoring. BR: breathing rate; TV: tidal 
volume, RIP: Respiratory inductive plethysmography; bpm: breaths per minute. 
System Wearable Sensor 
Working  
Principle 
Respiratory 
Parameters 
EquivitalTM EQ02 
LifeMonitor [49], [50] 
Chest strap RIP sensors 
Respiratory 
movements 
BR (0 to 70 
bpm) 
LifeShirt® [51] 
Elastic garment 
(Shirt) 
RIP 
sensors 
Respiratory 
movements 
BR, TV, minute 
ventilation 
ZephyrTM BioHarnessTM 
[52], [53] 
Chest strap 
Capacitive sen-
sors 
Respiratory 
movements 
BR (3 to 70 
bpm) 
 
Hexoskin® [54] 
Smart garment 
(Shirt) 
Inductive sensors 
Respiratory 
movements 
BR, TV, minute 
ventilation 
The Spire [55] Tag Force sensors 
Respiratory 
movements 
BR 
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1.2.3. Activity monitoring 
In the last decades, the importance of physical activity not only for fitness but also for wellbeing 
and health has called the attention of health providers and scientists. Several studies show its relevance 
on the progress and impact of many conditions such as cancer [56], [57], cardiovascular diseases [58], 
pulmonary diseases, diabetes and obesity, as well as on the outcome of several medical interventions 
[59], [60].  
The standard for physical activity and functional ability assessment in healthcare are questionnaire 
tools, validated functional tests, observations among other approaches. However, these methods are "ei-
ther time consuming and expensive, requiring access to specialized equipment and a dedicated labora-
tory set-up, or they are subjective and rely on clinician observation or patient recall"[61]. Furthermore, 
a short-term assessment does not always reveal the condition of the patient in his/her familiar environ-
ment. 
Objective measurement of subject's physical activity in home environment is possible through wear-
able sensors for activity monitoring. A significant part of the wearable devices for healthcare applica-
tions monitor activity. According to Mukhopadhyay [8], the most commonly used activity sensors are 
accelerometers, HR sensors, temperature sensors, and wearable ECG sensors. Even though gyroscopes, 
magnetometers, pressure sensors, microphones,  and camera- and depth-based systems have also been 
employed [7]. Among these, accelerometers, due to their simplicity and cost-effectiveness, are the most 
common.  
Continuous monitoring of users acceleration allows [6]–[8], [62]:  
▪ Activity recognition; 
▪ Classification of activity level; 
▪ Fall prediction and detection; 
▪ Posture recognition and analysis; 
▪ Balance assessment; 
▪ Metabolic expenditure estimation; 
▪ Gait/walking patterns assessment; 
▪ Sleep assessment. 
Additionally, accelerometers are often integrated into wearable devices to use their data in algorithms 
for motion artifacts removal from physiological signals, such as ECG [63].  
There are many wearable devices with integrated accelerometers suitable for measurements lasting 
several days, but there is no standard for activity monitoring in healthcare. Activity monitoring in home 
environment can be conducted in three modes [61]: clinical assessment, event monitoring and longitu-
dinal monitoring. 
1) Clinical assessment: Supervised, short-term monitoring. It aims to provide an objective clin-
ical examination of the subject's particular movements, in home environment. The acquired infor-
mation may be used as a complement to other physical activity and functional ability assessment 
approaches. 
2) Event monitoring: Unsupervised and long-term monitoring; real-time data processing. It aims 
to accelerate the response to emergencies. Thus, this mode of monitoring requires triggering an 
alarm each time an abnormal event is detected (e.g. fall or absence of movement). 
3) Longitudinal monitoring: Unsupervised, long-term monitoring. It aims to predict or prevent 
certain conditions. In this mode, parameters that quantitatively measure activity are monitored. 
Those parameters can be movement specific (for example step rate, postural sway and rise time) or 
not, which is the case for metabolic energy expenditure, amount of time spent resting and other 
general parameters of movement. In the first case, it is necessary to recognize the activity before 
measure the parameter, while in the latter there is no need for activity classification.  
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Wide ranges of physical activity parameters have been monitored [61]. Metabolic energy expendi-
ture; physical activity; posture; time in activity, total sleep/awake time; walking cadence (i.e. steps/mi-
nute); variability and intensity of activity are some examples. The most common is the metabolic energy 
expenditure.   
Although one of the main purposes of physical activity monitoring is to monitor physical activity, 
there is no consensus on the acceleration-derived parameters that should be used to this end. The most 
common parameters are step count [64]–[66] (i.e. number of steps), activity counts [67] (calculated after 
filtering, rectifying and aggreging acceleration over a time window [68], defined by the activity monitor 
manufacturer [69]), mean acceleration vector magnitude [70] (i.e. the average length of the acceleration 
vector) and vector magnitude units [71] (i.e. the vectorial sum of activity counts in three orthogonal 
directions), all calculated in 1 minute intervals. A study [72] used posture allocation to analyze sedentary 
behavior and inactivity. 
Apart from measuring physical activity, it is important to know its distribution (at which time of 
day/day of the week?), frequency (how many times?), duration (time in activity) and intensity in order 
to analyze the activity pattern. Thus, the acquired data must have the necessary time resolution.  
Some of the parameters proposed for the assessment of activity pattern based on acceleration are: 
a) Gini coefficient [65], [72]: very often used for comparing patterns of accumulation (i.e. how 
the total value was achieved), this coefficient measures inequality among values; ranges 
from 0 (complete equality, i.e. all values are the same; e.g. activity bouts contribute equally 
to the total activity time) to 1 (complete inequality, e.g. total activity time is due to a few 
long activity bouts); 
b) Intensity gradient [73]: measures physical activity distribution; it is the gradient of a sub-
ject's log-log linear regression which relates the activity intensity and the time accumulated 
at that intensity; 
c) Physical activity aggregation [64]: measures activity distribution over the monitoring pe-
riod, ranges from 0 (low aggregation, i.e. well spread over the monitoring period) to 1 (max-
imal temporal aggregation); 
d) Coefficient of variation [66] : measures the variability of activity, i.e. the dispersion or 
spread of physical activity, 𝐶𝑉 = 100 × 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛/𝑚𝑒𝑎𝑛; 
e) Approximate entropy [66]: measures the randomness of activity fluctuations, ranges from 
0 (short sequences of data points are perfectly repeatable) to 2 (any repeating sequences of 
points occur by chance alone); 
Since there is no standard method, there is still space for new approaches to quantitatively evaluate 
activity patterns.  
The majority of population-based studies that monitor physical activity for healthcare purposes [65], 
[67], [70] applied a longitudinal monitoring mode, with measurements lasting several days. The recom-
mended duration [71] is at least 7 days to ensure the reliability of the measurement. Wearing an activity 
monitor can lead subjects to, intentionally or not, increase their activity level. This effect, however, tends 
to decrease with increasing monitoring time. Moreover, subjects' routine may greatly vary from day to 
day, but it is more or less constant from week to week. 
Determining the "valid" monitoring period is also part of physical activity monitoring. One [64] can 
define the potential time of activity as the time in which the subject is awake. Thus, only data acquired 
while the subject was awake is taken into account in the activity pattern assessment. Others [64], [70] 
may consider that every time the subject can be active and so, all the data acquired while the subject 
wore the activity monitor is considered in the analysis. In the first case it is necessary a criterion to 
define sleeping periods and, in the second, a criterion must be set to determine the wearing time.  
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Accelerometer based physical activity monitoring is a very promising approach although it has also 
some limitations. One of them is that it is not suitable for monitoring activities such as resistance train-
ing, swimming or cycling. When the accelerometer is placed in central body location (e.g. waist or 
chest), information regarding movement of body extremities cannot be acquired. On the other side, soft 
tissue movement or external vibrations imposed on the body, for example while travelling in a motor 
vehicle, may add noise to the signal. A joint effort is needed to further explore this topic. 
ActiGraph, Axivity and GENEActiv accelerometers are the ones most often used in large global 
surveys [73]. Several companies, such as Fitbit [74], launched smart watches with integrated accelerom-
eters to monitor activity, recognize exercises and assess sleep quality. 
 
1.2.4. Multi-sensor monitoring systems 
The use of several wearable devices to monitor different physiological parameters is neither practi-
cal nor ergonomically sound, thus several multi-sensor systems have been proposed for continuous, 
long-term and remote health monitoring. However, almost none of those systems is already approved 
for clinical applications. Thus, they are being used for fitness or wellness purposes, while waiting for 
FDA and/or CE clearance. The approval of such devices will prompt advances in Telemedicine, begin-
ning a new phase in healthcare. 
VITALITI [75], develop by Cloud DX, is a wearable vital sign monitor that measures ECG, HR, 
oxygen saturation, respiration rate, core body temperature, blood pressure, movement, steps and posture. 
It enables 72 hours of continuous recording and is now undergoing FDA clearance for medical use.  
ZephyrTM BioHarnessTM [52], [53] is a multisensory chest strap “intended to monitor adults in the 
home, workplace and alternative care settings” [76]. The system monitors HR, breathing rate, activity 
level, subject orientation, skin temperature, blood pressure (optional external sensor) and blood oxygen 
saturation (optional external sensor).  It has been used for sports and academics/research purposes as 
well as to monitor first responders (e.g. firefighters), solders and astronauts. ZephyrTM BioHarnessTM is 
FDA-approved (510(k)). Its battery lasts 18 to 24 hours.  
Hexoskin® [54] is a smart shirt that monitors ECG, breathing rate, tidal volume, minute ventilation 
and tri-axis acceleration-derived parameters (activity intensity, peak acceleration, steps, cadence posi-
tions and best sleep tracker). The system has 12 to more than 30 hours battery life. The battery life was 
increased to 48 hours with Astroskin, a system developed by the same company to monitor astronauts. 
Astroskin monitors blood pressure, pulse oximetry, 3-lead ECG, breathing (RIP), skin temperature, and 
tri-axis acceleration (activity). Both systems have been used for academic and research purposes, first 
responders monitoring, defense, industrial, space and aerospace applications. 
Another example is EquivitalTM EQ02+ LifeMonitor [50], a device “intended for monitoring of 
adults (16-65 years) in hospital care facilities, the home, workplace, and alternate care settings” [76]. It 
is a wearable system that monitors ECG, HR, interbeat interval, respiratory rate, skin and core temper-
ature, galvanic skin response, oxygen saturation, PPG, and activity/body position through a tri-axis ac-
celerometer. The system has two components, the sensor electronics module and the sensor chest belt. 
It has FDA 510(k) clearance and is CE marked. This system was designed to provide "real-time mobile 
human data to keep healthy people healthy” [50]. It enables up to 48 hours of recording without recharge 
the battery and has been used to monitor people in extreme environments, i.e., soldiers, firefighters, 
athletes, miners etc.  
A summary of those four systems characteristics is presented in Table 1.4. Many more wearable 
systems have been proposed in the literature. Even though they are not yet applied for clinical applica-
tions, they already show the great potential of wearable technology in remote, continuous and long-term 
monitoring of physiological signs. 
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Table 1.4. Multi-sensor wearable devices for remote, continuous and long-term monitoring. HR: heart rate; BR: breathing 
rate; TV: tidal volume. 
System Wearable Parameters 
Battery 
Life 
Connectivity 
Market 
Clearance 
VITALITI [75] 
Chest and 
ear device 
HR, oxygen saturation, 
BR, core body tempera-
ture, blood pressure, ac-
celeration 
72 hours Wireless In process 
ZephyrTM Bio-
HarnessTM [52], 
[53] 
Chest strap 
HR, BR, skin temperature, 
blood pressure, blood oxy-
gen saturation, accelera-
tion 
18 to 24 
hours 
Wireless 
(Bluetooth), 
USB 
FDA 
510(k) 
Hexoskin® [54] 
Smart gar-
ment 
(Shirt) 
ECG, BR, TV, minute 
ventilation, acceleration  
12 to 48 
hours 
Wireless 
(Bluetooth) 
In process 
EquivitalTM 
EQ02 LifeMon-
itor [49], [50] 
Chest strap 
ECG, HR, interbeat inter-
val, BR, skin and core 
temperature, galvanic skin 
response, oxygen satura-
tion, PPG, and accelera-
tion 
Up to 48 
hours 
Wireless 
(Bluetooth), 
SD card 
FDA 
510(k) and 
CE 
 
 
This work aimed to assess the validity of the textile belt for electrocardiogram monitoring in a home 
setting and to supplement the existing system with sensors for respiratory monitoring. Another objective 
was to evaluate the suitability of the same wearable, as a multi-sensor system, for activity monitoring. 
The thesis is organized as follows: in Chapter 2 we assess the validity of Empa’s textile belt for ECG 
monitoring in a home setting through a study involving patients with suspected sleep apnoea; the inte-
gration of optical fibre-based sensors into the textile belt for respiratory monitoring is discussed in Chap-
ter 3 and, in Chapter 4, the proof of concept of an algorithm for activity monitoring using the data 
recorded by the textile belt (i.e. breathing rate, HR and tri-axis acceleration), as a multi-sensor system, 
is provided. Accelerometry-based body posture recognition is also discussed in the Chapter 4. A study 
was conducted to assess the validity of the textile belt for respiratory and activity monitoring. It is de-
scribed in Chapter 5. Finally, the general conclusion and future prospects of the project are presented in 
Chapter 6. 
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2.  ECG MONITORING 
The surface ECG is a continuous record of electrical signals, generated as a response of cardiac 
muscles to electrical impulses generated by pacemaker cells [15]. In this way, the ECG reflects the 
cyclic electro-physiologic events in the myocardium, revealing the condition of heart’s electrical func-
tion [16].   It has a critical role in detection of heart defects and cardiac diseases such as auricular or 
ventricular hypertrophy, myocardial infarction (heart attack), arrhythmias and pericarditis. ECG has also 
been used for emotion recognition and biometric identification [77], [78]. Figure 2.1 shows a typical 
ECG signal of a healthy subject. 
 
Figure 2.1. Example of ECG wave of a healthy subject. Image adapted from [79]. 
 
The ECG is characterized by its waves, segments and intervals [15]. The P wave corresponds to the 
atrial myocardium depolarization, the QRS complex (composed by Q, R and S waves) to the ventricular 
myocardium depolarization, the T wave to the ventricular myocardium repolarization and the U wave, 
unseen under normal conditions, in thought to be related with endocardial structures repolarization or 
ventricular myocardium depolarization [15], [80].  
One of the most relevant ECG features is the RR-interval, the time between consecutive R peaks. It 
is also called heart beat interval [81]. The analysis of HRV, i.e. the fluctuations in RR-intervals, is a 
straightforward way to study the autonomic nervous system activity.  Disease induced changes on HRV 
have been used for the diagnosis of several diseases, among them is sleep apnoea [82], [83]. 
Sleep apnoea syndrome is a disorder characterized by repetitive cessation of respiratory airflow 
during sleep. An apnea (Greek word which means “without breath” [84]) episode is the cessation of 
breathing for at least 10 seconds [85]. Apneas are classified as central or obstructive based on the ab-
sence or presence of respiratory effort (abdominal and chest wall movement), respectively. Mixed ap-
neas are periods of absent airflow that are initially associated with an absence of respiratory effort and 
that persist upon resumption of respiratory effort indicating upper airway obstruction [86].  Conse-
quently, sleep apnea is classified as central, obstructive or mixed according to the type of detected ap-
neas. In central sleep apnea the brain fails to send the appropriate signal to the breathing muscles, re-
sulting in cessation of the airflow. Obstructive sleep apnoea, in turn, is the obstruction of the upper 
airway due to pharyngeal collapse. It is more likely to occur when a supine posture is present since in 
this position gravitational effects are exerted on the tongue base and soft palate [87]. Partial occlusion 
of the upper airway is termed hypopnea. Apneas and hypopneas usually last 10 to 50 seconds, although 
hypopneas lasting several minutes may occur in rapid eye movement sleep [86]. 
Sleep apnoea syndrome severity is measured by the apnea-hypopnea index (AHI), which is the 
number of apneas and hypopneas per hour of sleep [4]. The gold standard for sleep apnea diagnosis is 
overnight PSG in a sleep laboratory. PSG incorporates recording of electroencephalogram, electro-
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oculogram, chin electromyogram, snoring (microphone), oronasal airflow (thermistor), ECG, pulse ox-
imetry and tibialis anterior electromyogram [82]. Due to the high cost of PSG and its obtrusiveness, 
alternative tools for sleep apnoea diagnosis have been explored. Approaches using oxygen saturation 
[88], snoring [89] and HRV analysis have been proposed [90].  
In this context, the applicability of Empa’s textile belt for overnight ECG monitoring was analyzed. 
A clinical study involving 242 patients with suspected sleep apnoea was carried out. Patients wore the 
textile belt while undergoing overnight PSG. RR-intervals derived from ECG signal recorded by the 
textile belt and the gel electrodes were compared. Results revealed that the belt enables RR-intervals 
measurement with high validity [28]. 
In this project, we would like to go a step further and explore the applicability of the same textile 
belt for ECG monitoring in home setting. No reference device was used in this study. Thus, a method to 
assess the quality of the acquired ECG signal, and consequently the validity of the textile belt for ECG 
monitoring in unattended setting, was developed. Existing approaches for ECG signal quality assess-
ment (SQA) are described below, as well as, the method we propose. 
 
2.1. Quality assessment of ECG signal 
The frequency range of diagnostic ECG signal is 0.05 to 100 Hz [91]. Generally, when the ECG 
recording is clean and the heart is in sinus rhythm (i.e. electrical impulse generated by the sinoatrial 
node [92]), QRS complex frequency ranges between 4 and 20 Hz, and P and T waves between 0.5 and 
10 Hz. Most ECG power is contained below 30 Hz [80].  
Real-world ECG signals are often corrupted by various noises. Seven types of noise mainly affect 
ECG signals [80], [81], [93]:  
a) Power line interference: noise caused by “differences in electrodes impedance and to 
stray currents through the patient and the cables” [94]. The noise has a frequency of 50 
or 60 Hz, and an amplitude equivalent to 50% of the peak-to-peak signal amplitude. 
Power line noise can be modeled as sinusoids or combination of sinusoids. 
b) Electrode contact noise: the loss of contact between the electrode and the skin results in 
abrupt baseline shifts which decays exponentially to the baseline value and has a super-
imposed component of 60 Hz. The noise can be permanent or intermittent and its am-
plitude equals the maximum recorded value.  
c) Motion artefacts: changes in electrode-skin impedance caused by subject’s movement 
result in transient baseline changes with a shape similar to one cycle of a sine wave. The 
baseline disturbance is of 500% of the peak-to-peak signal amplitude. 
d) Muscle contraction or electromyography noise: results from the contraction of non-car-
diac muscles. It can be assumed to be transient bursts of zero-mean band-limited Gauss-
ian noise, with a standard deviation of around 10% of the peak-to-peak signal amplitude. 
It has a wide frequency range (DC to 10 kHz). 
e) Baseline wander: baseline drift due to respiratory amplitude modulation. It can be rep-
resented as a low frequency sinusoidal wave (or combination of sinusoidal waves), of 
frequency between 0.15 and 0.3 Hz, and amplitude of 15% of the peak-to-peak signal 
amplitude. Sometimes baseline wander coincides with P and T waves frequencies. 
f) Instrumentation noise: noise arising from electronic equipment used for data acquisition 
and signal processing. 
g) Electrosurgical noise: noise of amplitude equivalent to 200% of peak-to-peak signal 
amplitude and frequency between 100 kHz and 1 MHz. It is produced by other medical 
apparatus used in parallel to ECG recordings. 
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Among them, power line interference and baseline wander are the most common. Although, when it 
comes to wearable devices, motion artefacts are predominant.  
Different approaches have been proposed to assess the quality of ECG signals. In the second chapter 
of a recently published book [91], Orphanidou gives an overview of the existing methods for automatic 
assessment of ECG signal quality, especially of data recorded by wearable devices. Depending on the 
device application, basic quality or diagnostic quality is required. In basic quality ECG signals, R peaks 
are clearly identifiable; the signal enables reliable calculation of HR as well as extraction of HRV infor-
mation. In ECG signals of diagnostic quality, QRS complex, P, if present, and T waves are clearly 
identifiable; the signal can be used for clinical diagnosis.  
In summary, single- and multi-channel SQA approaches have been proposed. Some algorithms are 
based on time domain, while others on frequency domain features obtained from the ECG signal. The 
first step of SQA algorithms is beat detection. Then, feasibility checks are applied to differentiate be-
tween acceptable (i.e. high quality) and unacceptable (i.e. low quality) signal segments. Flat line detec-
tion, amplitude limits and variability, baseline wander, noise power measures and physiological feasi-
bility have been used for SQA.  
Flat signal segments are a sign of a missing lead as ECG signal is never constant. Therefore, the 
detection of zero or constant difference between consecutive points during a predefined time has been 
used for flat line recognition [95]. As mentioned before, several noises (e.g. motion artefacts, power line 
interference and electrode contact noise) affect signal baseline, resulting in a wide amplitude range. 
Thus, amplitude limits are an indicator of signal quality. Thresholds for minimum and maximum am-
plitude are set and, depending on the percentage of the signal outside the acceptable range, a signal 
segment is classified as acceptable or not [96]. Baseline wander (BLW) can be identified using a low-
pass filter. A signal segment is classified as unacceptable if the BLW exceeds an empirically set thresh-
old [97]. 
 Noise-power measures rely on the assumption that the noise is gaussian and the signal stationary, 
which is not always true. Therefore, it is recommended to complement noise-power measures with other 
techniques that can cope with noises that do not meet these criteria. Root mean square power in the 
isoelectric region (i.e. region between the P wave and the QRS complex, thought to be a marker for 0 
V), the ratio between in-band and out-of-band spectral power and the power in the residual after a fil-
tering process, are some of the proposed noise-power measures [98], [99].  
Lastly, signal classification using physiological feasibility relies on the well-defined range and var-
iability of RR-intervals. The average HR (should be between 40 and 180 beats per minute), the maxi-
mum RR-interval (usually set to 1500 ms), the ratio between the maximum and the minimum RR-inter-
vals (e.g. should not exceed 1.1 in a signal segment of 10 second as change in HR over 10% is improb-
able in such a short time period) have been used to reject signal segments with data that is not physio-
logically viable [100]. Care should be taken, however, when using physiological feasibility for SQA as 
it is not possible to differentiate between signal variability arising from noise and from cardiac abnor-
malities, such as ectopic beats (i.e. abnormal beats that are due to unusual impulses [101], they add 
variability to the RR-intervals).  
Given that the heart follows a regular rhythm and that noise can deform ECG wave morphology, 
trend-based methods have been used to search for regularity in signal segments. It is assumed that the 
more regular an ECG segment, the higher its quality and, consequently, the more reliable is the infor-
mation extracted from it. Skewness and kurtosis, which measure the symmetry and shape of a distribu-
tion, have been used to assess the regularity of ECG signal segments [102], [103]. The variability in RR-
intervals, indicated for example by their standard deviation [104], and the correlation between each 
individual QRS complex and the reference QRS complex of the segment (often taken as the average of 
all QRS complexes detected in the segment), termed template matching [100], have also been used as 
signal quality indices.  
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Frequency domain approaches include analyzing the signal’s frequency content in different band-
widths and spectral analysis of the HRV. Noise-power measurement methods, described previously, can 
be considered frequency domain methods. Those methods usually require the use of fast Fourier trans-
form (FFT). The measurement of entropy in the different decomposition levels and other discrete wave-
let transform-based methods have also been proposed for SQA [105], [106]. 
All signal quality indices mentioned before can be combined to provide a more robust SQA ap-
proach. Different measures have been combined through decision rules [107] or machine learning mod-
els [108]. Thresholds are applied individually to measures or classifiers, and the signal segment is clas-
sified as acceptable or not accordingly. Physiological limitations, the expected limits of signal features 
and empirical evidence are used to determine those thresholds. When ECG signal is acquired by multiple 
channels, the correlation, covariance as well as the agreement between QRS complex detected in the 
data from different leads have been deployed for SQA [109], [110].  
We aimed to assess the quality of the ECG signal acquired in a home environment. Since the main 
application of the belt in the context of this study was to provide information regarding HRV for sleep 
apnoea detection, basic quality ECG signal is required (i.e. R peaks are clearly identifiable). 
The most relevant ECG signal features are in the frequency range between 0.5 and 40 Hz [99], 
including the QRS complex. For this reason, ECG signals are often band-pass filtered in this frequency 
range [81].  Given these facts, we categorized the noises according to the frequency of their components: 
low-frequency, i.e. noise of frequency lower than 0.5 Hz, and high-frequency noise, i.e. noise of fre-
quency higher than 40 Hz. BLW is a low-frequency noise, while power line interference, electrode con-
tact noise and electrosurgical noise are considered high-frequency noise.  
We used the signal-to-noise ratio (SNR), a standard measure of signal quality, to evaluate the impact 
of noise on the signal. The ratio between the signal power and the low-frequency noise power, referred 
to as SNRlf, as well as between the signal power and the high-frequency noise power, referred to as 
SNRhf were computed. Low-frequency noise was extracted from the raw ECG signal using a second-
order low-pass FIR filter with cutoff frequency of 0.5 Hz, and high-frequency noise was obtained using 
a high-pass FIR filter of the same order, with cutoff frequency of 40 Hz. The band-pass filtered signal 
was taken as the reference signal. Signal’s BLW was estimated based on the average amplitude of the 
low-frequency noise. 
SNR, however, relies on the assumption that the noise follows a gaussian distribution, which is not 
always the case. To cope with non-gaussian and transient noises, such as motion artefacts, the physio-
logical acceptability of the RR-intervals derived from the raw ECG signal was analyzed. This is because 
the presence of some noises and artefacts in the signal, e.g. motion artefacts, electrode contact noise and 
electrosurgical noise, lead to the appearance of peaks that can be falsely detected as R peaks. Moreover, 
due to BLW, T peaks can be higher than R peaks, leading to same false detection. Finally, this leads to 
the computation of incorrect RR-intervals. Therefore, the physiological acceptability of recorded RR-
intervals is another indicator of the quality of ECG signal. 
 For this purpose, RR-intervals were filtered using the algorithm described by Fontana et al. [28]. 
RR-intervals shorter than 300 ms or longer than 1500 ms were rejected and considered as artefacts. 
Likewise, RR-intervals differing in more than 20% from the median of the ten preceding or following 
RR-intervals were excluded from further analysis as such a difference is not considered to be physio-
logically acceptable. The artefact percentage of each ECG recording was taken as the number of artefacts 
divided by the number of recorded RR-intervals. Artefact percentage was considered with respect to 
subjects lying position to analyze the impact of lateral pressure, which is expected to disrupt the contact 
between the electrodes and the skin, on signal quality. 
Even though SNRlf, SNRhf, BLW and artefact percentage address different types of noise and ena-
bling SQA, none of them allows differentiation between artefacts arising from noise and artefacts arising 
from ectopic beats. Classifying abnormal disease related events, e.g. arrhythmic events, as noise is a 
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common limitation of signal quality indices [111]. Differentiating between ectopic beats related and 
noise related artefacts is especially critical in this study as sleep apnea has been strongly associated with 
arrythmia [112], which increases RR-intervals variability. Therefore, we propose to apply Poincaré plots 
to differentiate between ectopic beats related and noise related RR-Intervals.  
Poincaré plots are a quantitative and visual non-linear method to analyze HRV [15], [113]. It con-
sists in plotting each RR-interval against the previous one. Apart from allowing the analysis of RR-
intervals distribution, the visual assessment of the distribution pattern has been proved to be a tool for 
cardiac dysfunction prediction [114], [115], while enabling immediate recognition of ectopic beats and 
artefacts [115], [116].  A Poincaré plot not affected by cardiac dysfunction or noises is presented in 
Figure 2.2. The pattern for such a representation is called comet-shaped pattern. It reflects low variability 
in short-term (axis 2 direction) and high variability in long-term (axis 1 direction) while showing an 
asymmetry in relation to axis 2.  
 
 
Figure 2.2. Example of Poincaré plot of a healthy subject. SD1 is the ellipse width (blue line), and SD2 the ellipse length (red 
line). Image adapted from [117].   
 
Poincaré descriptors, SD1 and SD2, are used to quantitatively describe its geometry. When an el-
lipse is fitted to the data, as shown in Figure 2.2, SD1 corresponds to the width of the ellipse and SD2 
to the length of the ellipse. The ratio between SD1 and SD2, SD1/SD2, provides an indicator for the 
randomness of HRV. SD1 and SD2 are calculated using equation 2.1 [118]. It has been proved that SD1 
and SD2 values increase with increasing occurrence of artefacts and ectopic beats [119].   
 
𝑆𝐷1(𝑆𝐷2) =
1
𝑛
∑
((𝑥𝑖−(+)𝑦𝑖)−(𝑥−(+)𝑦̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅))
2
2
𝑛
𝑖=1                                        (2.1) 
 
x is the vector containing the detected RR-intervals, from the first to the penultimate; and y, the 
vector containing the detected RR-intervals, from the second to the last. n is the number of points in the 
Poincaré plot, which equals the number of detected RR-intervals minus one.  
Poincaré plots showing a very low dispersion of RR-interval in the axis 2 direction are termed Tor-
pedo-shaped; when RR-intervals are dispersed in a very symmetric way in relation to axis 2, the pattern 
is termed fan-shaped pattern; and when RR-interval are grouped in more than one cluster, the pattern is 
called complex, see Figure 2.3. The Torpedo-shaped, the fan-shaped as well as grouping in multiple 
 19 
 
clusters are considered to be pathological [114]. Since noise is, by nature, uncorrelated and random, the 
presence of noise results in highly dispersed points in the plot [117]. Although Poincaré plots have been 
used to visually assess the quality of recorded ECG [118], the assessment of its pattern for SQA purposes 
has not been fully explored.  
 
 
Figure 2.3. Example of pathological Poincaré plots. B: Torpedo-shaped pattern; D: Fan-shaped pattern; F: Complex pattern. 
Image adapted from [114]. 
 
In summary, we propose the use of SNRlf and SNRhf to assess the quality of the signal in terms of 
gaussian noise, BLW to evaluate the baseline drift, artefact percentage to measure the occurrence of 
artefacts due to any type of noise or physiological abnormality and, finally, Poincaré plots to determine 
the primary source of artefacts, i.e. ectopic beats (physiological abnormality) or noise (device malfunc-
tion). 
 
2.2. Study: ECG monitoring in a home setting 
From the 242 patients that participated in the clinical study, 12 consented to participate in this study. 
A description of the study participants is shown in Table 2.1.  
Patients were asked to wear the textile belt for one to three consecutive nights, having received 
instruction on how to mount the belt during their stay in the hospital. The belt’s data logger (Faros 180◦, 
Bittum Corporation, Oulu, Finland) was activated by study nurses, consequently, subjects’ ECG signal 
was continuously recorded during the whole period of participation in the study.  
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Table 2.1. Description of study participants. Comparison with the clinical study. BMI: body mass index. AHI: apnea-hypopnea 
index. 
 Full data set of the clinical 
study  
Subgroup of this 
study 
n 242 12 
Age (y) 52 [43-61] 54 [48-59] 
male/female 186 / 56 10 / 2 
BMI (kg·m-2) 29 [25.5-32.5] 30.0 [28.0 – 35.5] 
AHI (h-1) 21 [4.4 – 37.6] 14.8 [8.6 – 38.5] 
Type of apnoea Obstructive 156 8 
 Central 5 1 
 Mixed 35 1 
 Unspecified 1 0 
 No apnoea de-
tected 
44 2 
 
Selection of valid monitoring periods 
After completion of data collection, a single ECG recording was obtained for each patient. Thus, 
monitoring periods, i.e. nights, had to be selected from the recordings. The first and last point of moni-
toring periods were determined manually. Since patients were instructed to only wear the belt when 
going to sleep, the starting point of a valid monitoring period was considered  to be the “first ECG signal 
segment clear enough to be recognized as such, after several hours without any recorded ECG signal” 
[27]. Likewise, “the end of each monitoring period was defined as the last ECG signal recorded before 
a long period of signal absence.” [27]. Data recorded by an acceleration module integrated in the ECG 
data logger was considered for the confirmation of selected monitoring periods. ECG data was recorded 
with a sampling frequency of 250 Hz, and tri-axis acceleration with a sampling frequency of 10 Hz. 
Acceleration data was also used to recognize subjects’ lying position. 
 
Signal processing and data analysis 
R peaks were detected using Kubios HRV Premium Software, Version 2.2 (Kubios Oy, Kuopios, 
Finland). RR-intervals were computed by the same software. Signal processing algorithms were imple-
mented in MATLAB R2018a (The MathWorks, Inc., Natick, MA, USA). All statistical analysis was 
carried out using R, version 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria). The author 
used Microsoft Excel (Microsoft Corp., Redmond, Washington, USA) for calculations. A p value of less 
than 0.05 was accepted as the level of statistical significance. Hereafter, data is presented as average 
value ± standard deviation. 
  
2.2.1 Results and discussion 
A total of 28 valid monitoring periods (i.e. nights) were identified, three nights in seven patients, 
two nights in two patients, and one night in three patients. The average duration of nights was 7.7 ± 1.2 
h. The quality of the data acquired by the textile belt in the home setting (ECG-belt home) was assessed 
and compared to the quality of the data acquired by the gel electrodes (Gel electrodes) and the textile 
belt (ECG-belt hospital) during the clinical study.  
The ECG signal acquired in the home setting had a good quality (Table 2.2). SNRlf and SNRhf were 
found to be high showing values similar to those of the data acquired by the gel electrodes in clinical 
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setting. Likewise, BLW of the ECG signals acquired by the belt in home environment is much lower 
than the one of the data acquired by the same device in the hospital, being close to the BLW of the data 
acquired by the gel electrodes. A great improvement was noticed on the data quality acquired by the 
textile belt when compared to the clinical study data, especially in terms of low-frequency noise.  
 
Table 2.2. Comparison of the quality of ECG signals recorded in the hospital (Gel electrodes and ECG-belt hospital) and at 
home (ECG-belt home). 
 SNRlf SNRhf BLW 
Unit dB dB mV 
Gel electrodes 12 ± 5  21 ± 3 0.03 ± 0.02 
ECG-belt hospital 0 ± 5 17 ± 6 0.30 ± 0.43 
ECG-belt home 11 ± 2 21 ± 5 0.05 ± 0.02 
 
In average, 7.49% of the RR-interval derived from the ECG signals acquired by the belt were con-
sidered as artefacts. Even though the artefact percentage was lower than the one of the data acquired in 
clinical environment, it was still higher than the one of the gel electrodes, see Table 2.3.  
 
Table 2.3. Artefact percentage of RR-intervals derived from the ECG recordings. Data of the gel electrodes (Gel electrodes) 
and the ECG-belt (ECG-belt hospital) in hospital and of the ECG-belt in home environment (ECG-belt home). 
 
 
Poincaré plots revealed to be effective for determining the primary source of artefacts, whether ec-
topic beats or noise (Figure 2.4).  
 Gel Electrodes ECG-belt hospital ECG-belt home N 
Average 2.87% 9.66% 7.49% 
12 Median 1.41% 5.38% 2.77% 
SD 4.14% 14.65% 10.76% 
 22 
 
 
Figure 2.4. Example of Poincaré plot. A: artefact percentage of 0.2%; B: artefact percentage of 6.2%, artefacts caused by 
pathophysiological issues; C: artefact percentage of 11.3%, artefacts caused by noise. Unfiltered RR-intervals. Image and 
caption taken from [27]. 
 
While in A the low artefact percentage indicates a good ECG signal quality, in C ECG signal was 
corrupted by power line noise, resulting in a high artefact percentage and a consequent highly scattered 
points distribution [117]. In B, the artefact percentage is also high, i.e., higher than 5%. However, Poin-
caré plot distribution shows a complex pattern, indicator of heart disease [120]. Thus, artefacts do not 
arise from low quality ECG signal, but are characteristic of the subject. Interestingly, a similar complex 
pattern was also found for data of the same subject acquired in other two nights (see Figure A11 in 
Appendix A). The suspect of cardiac disease was confirmed, proving once again the potential of Poin-
caré plots for HRV analysis. In line with other works, Poincaré plot descriptors were found to be signif-
icantly correlated with artefact percentage, especially SD1 (see Table 2.4). 
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Table 2.4. Correlation between artefact percentage and Poincaré plot descriptors (SD1, SD2 and SD1/SD2). Filtered RR-
intervals; patient with cardiac disease was excluded. 
 Correlation  p 
SD1 0.80 < 0.001 
SD2 0.47 0.02 
SD1/SD2 0.62 < 0.001 
 
We found that an artefact percentage of 3% or lower was associated with a very clean Poincaré plot, 
i.e. clear pattern with almost no artefacts due to ectopic beats nor noise. Interestingly enough, the aver-
age artefact percentage of the data acquired by the gel electrodes during the clinical study was 2.87%, 
which corroborates our finding. Artefact percentages equal or lower than 3% were found for 15 of the 
28 nights (53.6%). Furthermore, 4 of the 13 nights with artefact percentage higher than 3% had ectopic 
beats as the primary source of artefacts (see Figures A10 and A11 in Appendix A). Thus, the data ac-
quired by the textile belt was found to be of low quality only in 9 of the 28 nights (32.1%). Poincaré 
plots also showed that the RR-intervals filtering algorithm greatly improved the quality of RR-intervals 
data (see Poincaré plots in Appendix A). 
Even though the textile belt is more sensitive to noise than the gold standard (i.e. its data has a higher 
artefact percentage), a mean difference of -32.69 ms was found between the average RR-interval of the 
data acquired in the home setting and the data acquired by the gel electrodes in clinical setting. The 
mean difference increases to -42.45 ms when compared to data recorded by the textile belt in clinical 
setting. Given that home measurements were conducted on different nights in a different environment, 
this difference can be considered as acceptable. Besides, average RR-intervals measured in the different 
settings were found to be highly correlated (Pearson r of 0.78, p = 0.003). It shows good agreement 
between RR-intervals derived from the ECG recordings in home and clinical settings.   
Finally, Figure 2.5 shows the artefact percentage according to subjects lying position. Data was 
considered for analysis only when recordings for subjects remaining more than 1 minute in the same 
position were obtained. In accordance with the conclusions of the clinical study, lying in a lateral posi-
tion is associated with increased artefact percentage. It is thought to be caused by loss of contact between 
electrodes and the skin due to belt deformation induced by lateral pressure.  
 
 
Figure 2.5. Boxplot of artefact percentage according to subjects lying position. Black line indicates the median; gray area 
indicates the interquartile range. Whiskers extended from minimum to maximal values. 
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The results of the SQA of the ECG signal acquired by the textile belt in the home setting were 
published by Fontana et al. [27] including further discussions of the results.  
 
2.2.2 Conclusions 
Our results revealed that ECG signals acquired by the textile belt in the home setting achieved better 
quality than the data acquired by the same device in clinical setting. It has a higher SNR, actually similar 
to the one of ECG signals acquired by the gel electrodes, and a lower artefact percentage. Even though 
the data recorded in the home setting has a higher artefact percentage than the data acquired by the gel 
electrodes, a good agreement was found between the RR-intervals derived from ECG recorded in the 
two settings.  
Poincaré plot analysis showed the suitability of the textile belt to record reliable ECG signals, even 
in a home environment. Visual assessment of Poincaré plots proved to be effective for the determination 
of the primary source of artefacts (noise or ectopic beats). The development of an algorithm for auto-
matic recognition of Poincaré plot pattern would be of great value, as the need of human intervention is 
the main limitation of this technique.  
It is unclear why data recorded in the home setting is of higher quality than the data obtained in 
clinical setting. As a low number of patients were included in this study (pilot study), a follow-up study 
and further research is needed. In this study no information regarding the way patients handled the belt 
neither regarding possible ‘artefacts sources’ present in the monitoring environment was available. A 
deeper analysis must be conducted in order to better understand the behavior of the belt, especially the 
possible sources of artefacts and their effect on signal quality (e.g. wear the belt in a wrong way, pres-
ence of electronic devices near the belt, etc.). Such a study must be conducted in a controlled environ-
ment. The effect of body posture was analyzed; however, it would also be interesting to analyze the 
effect of movement due to posture transitions on signal quality. 
The use of the textile belt in a home setting enables continuous, remote and non-invasive ECG 
monitoring, while ensuring patients’ comfort. It would be valuable not only for the pre-screening of 
patients with suspected sleep apnoea, but also for long-term monitoring of patients  suffering from sleep 
apnoea and other sleep-related disorders that affect HRV as well as the observation of treatment efficacy 
[27].   
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3. RESPIRATORY MONITORING 
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4. ACTIVITY MONITORING 
In recent years, the importance of physical activity for both physical and mental health has been 
proved. Physical inactivity was pointed as the fourth leading risk factor for mortality, following high 
blood pressure, tobacco use and high blood glucose [121]. Several studies have highlighted the crucial 
role of physical activity in the reduction of risk for cardiovascular diseases [122]–[124] and cancer 
mortality [125], [126], as well as for the improvement of mental health [127], [128]. Furthermore, 
physical activity improves the quality of life of patients suffering from different diseases, for example 
fibromyalgia [129] and autoimmune diseases [130], and reduction in activity level is an early sign of 
Parkinson disease [131]. As a result, an effort to increase public awareness on the risk of a sedentary 
lifestyle has been done. Activity monitors play a major role in achieving this purpose. 
A brief discussion on the relevance of physical activity intensity and body posture recognition for 
activity monitoring is presented in this chapter. Algorithms for determining activity intensity and 
recognizing body posture based on the data from the acceleration module integrated in the ECG-belt 
logger are proposed here. 
 
4.1. Physical Activity Intensity 
Given the strong scientific evidences of the benefits of an active lifestyle, in 2010 the WHO 
launched the Global Recommendations on Physical Activity for Health [121]. It aimed to prevent non-
communicable diseases (often called chronic diseases), the leading cause of death worldwide [132], 
through physical activity at population level. In this book, the WHO addresses the recommended level 
of physical activity for adults and children aged 5 years and older. As an example, recommendations for 
adults aged between 18 and 64 years, are the following: 
1. Adults aged 18–64 should do at least 150 minutes of moderate-intensity aerobic physical 
activity throughout the week, or do at least 75 minutes of vigorous-intensity aerobic physi-
cal activity throughout the week, or an equivalent combination of moderate- and vigorous-
intensity activity. 
2. Aerobic activity should be performed in bouts of at least 10 minutes duration. 
3. For additional health benefits, adults should increase their moderate-intensity aerobic phys-
ical activity to 300 minutes per week, or engage in 150 minutes of vigorous-intensity aero-
bic physical activity per week, or an equivalent combination of moderate- and vigorous-
intensity activity.  
4. Muscle-strengthening activities should be done involving major muscle groups on 2 or more 
days a week. [121, p8] 
These recommendations show that a comprehensive description of physical activity, it is important to 
get information about the duration (“For how long”), frequency (“How often”), intensity (“How hard a 
person works to do the activity”) and volume (“How much in total”) [121]. Therefore, any device 
intended to monitor physical activity for healthcare purposes must be able to provide this information. 
Activity duration, frequency and volume, as well as information regarding activity distribution, i.e. time 
of the day/day of the week, simply rely on the acquisition of data with the necessary time resolution. 
However, determining physical activity intensity implies the knowledge of the activity specific energy 
expenditure.  
In [133], [134], the different techniques to measure energy expenditure (EE) are presented. Self-
reporting methods were one of the first approaches used to assess physical activity and are still widely 
used in clinical practice. Nevertheless, self-reporting methods rely on subjects’ memory and perception 
[135], [136]. Thus, in spite of their low cost, these methods have low reliability and accuracy when 
assessing physical activity EE [137]. 
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 The gold standard for measuring total energy expenditure (TEE) is the doubly labeled water 
(DLW). It consists on the ingestion of a known dose of 2H218O and 2H216O and calculation of the TEE 
based on the difference between the elimination rates of the two isotopes. Elimination rates are 
determined through analysis of urine, saliva or blood samples, collected at different times during the 
measurement period, by mass spectroscopy [138]. DLW enables measuring the average daily TEE under 
free-living conditions with high accuracy and is non-invasive. Despite that, it is expensive, requires 
qualified personnel and implies samples collection.  
Other popular techniques for EE measurement are the direct and the indirect calorimetry. The direct 
calorimetry enables the determination of subjects’ metabolic rate based on the measurement of their rate 
of heat loss using a calorimeter. Subjects must be in an insulated chamber during the measurement. It is 
the most accurate method to measure metabolic rate but is also costly and a burden for participants. The 
indirect calorimetry is the most commonly used technique to measure EE. It is an accurate and non-
invasive method. Weir’s formula is used to calculate EE based on the volume of consumed O2 and 
produced CO2, quantified through the measurement of the concentration of the two gases as well as the 
inspired and expired volumes of both. Douglas bag, canopy or facemask are used to measure gas 
concentration and volume, which makes the procedure impractical, especially in free-living 
environment. 
EE can also be estimated based on physiological variables such as HR [139]–[141], core temperature 
[142] and pulmonary ventilation volume [143], [144]. It is known that HR is linearly related within a 
particular range of EE [145], thus the later can be indirectly measured after finding the linear function 
that describes this relation [145], [146]. Apart of being non-invasive, it is more affordable than the other 
methods and allows free-living measurement of EE using HR monitors. This method has, however, two 
main limitations: the linear relationship between EE and HR varies from subject to subject and it 
deteriorates at sedentary and very intense activities [145]. Despite these limitations, the level of physical 
activity has been determined based on the HR [147], [148]. 
Additionally, motion sensors, such as accelerometers and pedometers have been used to estimate 
EE. Pedometers measure the number of steps a person takes in a certain time interval. They are low cost 
and unobtrusive, yet inaccurate for EE estimation. Even so, the number of steps per minute (cadence) 
has been used to determine physical activity intensity [149]–[151]. Accelerometers measure the 
acceleration exerted upon the sensor with reference to the gravitational force, g (g = 9.81 m/s2), in one 
to three orthogonal directions [133], [152]. They enable long-term activity monitoring in free-living 
populations and provide information regarding the volume, frequency, intensity and duration of physical 
activity [153]. Prediction models have been developed to estimate EE based on acceleration derived 
parameters, though their application is limited [134], [154]. Accelerometer based EE estimation is a low 
cost, reliable, objective and practical method, however studies revealed that the estimation accuracy is 
low for sedentary-to-light activities [155] and that the linear relation between acceleration and EE 
depends on the type of activity performed [156], [157]. 
The most frequently used reference measure of activity intensity is the metabolic equivalent of the 
task (MET) which is expressed as energy expended per body mass and time (1 MET = 1 kcal/(kg body 
mass.h))  or as metabolic power per body surface area (1 MET = 58.2 W/m2). 1 MET represents the 
resting metabolic rate, defined as the energy cost of sitting quietly [158]. Activity intensity is usually 
divided in three levels: light (<3METs), moderate (3-6 METs) and vigorous (>6 METs) [131], [147], 
[149], [154].   
The WHO considers moderate-intensity physical to increase HR above resting HR and vigorous-
intensity physical to substantially increase HR and cause rapid breathing [158]. Given that Empa’s 
textile belt enables HR and  breathing rate (BR) monitoring, and has an acceleration module integrated 
in the ECG logger, the use of all these parameters to determine physical activity intensity was explored. 
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4.1.1. Algorithm for physical activity intensity classification 
As mentioned above, HR has been used to determine physical activity intensity. It is done by 
calculating the percentage of the maximal HR (HRmax), called %HRmax. American College of Sports 
Medicine (ACSM) guidelines [147] define light-intensity activities as requiring more than 50% HRmax, 
moderate-intensity as requiring more than 64% HRmax and vigorous-intensity as requiring more than 
77% HRmax. The HRmax is often taken as the age-predicted HRmax, calculated using the formula HRmax = 
220-age [135]. 
In [148], light-intensity activity is associated with a slight increase in BR, moderate-intensity with 
a more notable increase in BR and vigorous-intensity with being more out of breath. In contrast with the 
HR or the oxygen uptake, so far, the BR has not been considered to assess physical activity intensity. 
However, recently a paper entitled “Respiratory Frequency During Exercise: The Neglected 
Physiological Measure” [159] aimed to put the attention to the relevance of BR as a marker of physical 
effort. Nicolò and co-authors listed several advantages of considering BR for training monitoring based 
on the existing scientific evidence. BR response to incremental exercise is approximately linear; BR 
time course has been proved to be related with that of Rating of Perceived Exertion (RPE), which is a 
subjective measure of physical activity intensity; and BR may be an indicator of time to exhaustion. 
Most interestingly, and in contrast with HR and other physiological parameters, BR responds very fast 
to changes in effort which occur due to workload variations. Moreover, the relation between BR and 
physical effort does not depend on the active muscle mass nor on the metabolic requirements of the 
activity. In their paper, Nicolò and colleagues suggest methodologies on how to analyze BR data. They 
propose the normalization of BR by relating it to the maximal BR (BRmax), in a similar way as %HRmax. 
This would handle the great variability of the BR and therefore facilitate data analysis and generalization 
of conclusions. Yet, it implies conducting tests to measure BRmax or take the maximum BR recorded 
during the monitoring period as the BRmax. A first study analyzed the suitability of BR normalized to 
BRmax for the assessment of physical activity effort. Their findings revealed a high correlation between 
the percent of BRmax and RPE [160].  
We propose the use of the ratio between the BR and the resting BR (BRrest) as an indicator of physical 
activity intensity. Even though it does not have a well-defined range of variation as the percentage of 
BRmax, it is easier to measure BRrest than BRmax. Thus, normalization of BR to BRrest, through the formula 
BR/ BRrest, may be another way to normalize BR.  
As the HR, accelerometry has been commonly used for physical activity intensity classification. In 
fact, accelerometers are the sensors most commonly used for activity monitoring, of which ActiGraph 
accelerometers are the most popular. Since the output of ActiGraph accelerometers was not the raw 
acceleration (available for newer ActiGraph accelerometers) but counts per unit time, counts is the most 
used metric of physical activity [68]. Consequently, activity intensity has been widely determined based 
on the number of counts per minute [67], [129], [161]. Nevertheless, since the definition of activity 
count varies among devices, the use of raw acceleration data has been advised to ensure comparability 
between studies. In this way, several studies [73], [162], [163] classified activity intensity based on cut 
points for the average acceleration, usually presented in milligravity (mg).  
Though accelerometry is an objective method to measure physical activity, the same activity may 
require different effort for different subjects since the intensity of physical activity also depends on 
subject's fitness, age and gender, for example. Besides, in the system proposed in this work, the 
accelerometer is placed in the anterior chest. It is a good position to record motions that involve 
displacement of the entire body, yet information regarding movement of body extremities cannot be 
acquired and activities such as resistance training, swimming or cycling cannot be adequately recorded 
[156], [157]. On the other hand, HR and BR vary with physical activity, regardless of the activity type, 
and reflect individual characteristics. However, both change as a body response to emotional, 
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physiological and environmental factors [164]. Therefore, combining HR, BR and acceleration is a 
sound manner to overcome the limitations of each parameter.  
The combination of HR and acceleration to estimate EE has been widely explored, and results 
proved that it improves estimation accuracy when compared to models using HR or acceleration only 
[165]–[167]. In [168], a wearable device that monitors HR through electrocardiography, relative tidal 
volume through impedance pneumography and acceleration from upper and lower limbs is presented. 
A multilayer perceptron neural network model for EE estimation was developed. The model includes 
%HRmax, normalized relative ventilation (i.e. ratio between the sum of the relative tidal volumes 
measured in a short time interval and the maximal relative ventilation) and mean absolute value of wrist 
and thigh acceleration as input features. Results show a good agreement between model estimates and 
reference methods. Preliminary tests of another wearable system for activity monitoring is presented in 
[169]. This wearable device monitors BR, HR and movement cadence by a variable-orifice meter 
combined with a differential pressure sensor, a photoplethysmographic sensor and an IMU unit, 
respectively, in real time. Even though the system was designed for activity monitoring, methods for the 
use of the measured parameters for this purpose were not explored. In [170], EE was estimated based 
on different parameters such as acceleration (activity, acceleration peaks count), HR, BR, chest skin 
temperature, galvanic skin response, arm skin temperature and ambient temperature. Different 
regression models were applied for the different parameters and combined the outputs by calculating 
the median. The combination of the different models resulted in a lower mean absolute percentage error.  
The proof of concept for activity intensity classification based on the combination of HR, BR and 
acceleration monitored by the textile belt was developed. The acceleration module of the belt’s data 
logger records acceleration in three orthogonal axes. After data acquisition, the raw data is filtered using 
a third-order elliptical filter (cutoff frequency: 0.3 Hz, passband ripple: 0.1 dB, stopband: −100 dB) 
[171] in order to separate inertial acceleration (ic), associated with body movement, from gravitational 
acceleration, which is related with body posture. For each axis, ic was integrated by calculating the 
Euclidean norm. The inertial acceleration magnitude is given by  
 
𝑖𝑐 = √𝑖𝑐𝑥
2 + 𝑖𝑐𝑦
2 + 𝑖𝑐𝑧
2                                                       (4.1) 
 
The inertial acceleration magnitude is, afterwards, averaged in 30-second epochs, without overlapping. 
BR and HR are averaged in the same manner. HR is derived from the measured RR-intervals, according 
to the formula 
𝐻𝑅 =
60
𝑅𝑅
                                                                  (4.2) 
 
where RR is the RR-interval (in seconds) calculated from the ECG signal. 
The algorithm for activity intensity classification consists of finding the discriminants that enable 
correct classification of activities as light, moderate or vigorous, based on single parameters, and 
combining classifications using four rules. The discriminants for HR [147] and acceleration [70], [73], 
[158] were determined based on the available literature, while the discriminants for the BR were 
empirically determined. All thresholds are presented in table 4.1. 
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Table 4.1. Discriminants for activity intensity classification. 
 Discriminants 
Moderate Vigorous 
%HRmax 64% 77% 
Ratio BRrest 1.5 2 
ic 80 mg 500 mg 
 
Depending on the parameters value of a given 30-second epoch, the activity performed by the 
subject is classified as light, if the value is less than the cut point for moderate-intensity activity; 
moderate, if  the value is equal or higher than the moderate-intensity cut point; and vigorous, if it is 
equal or higher than the vigorous-intensity cut point. 
The different classifications, based on HR (cHR), BR (cBR) and inertial acceleration (cIc) are 
combined using four basic rules: 
1) If the average acceleration over a certain epoch was lower than 20 mg, the epoch is classi-
fied as inactive, and no activity level is assigned to that epoch; 
2) If cHR, cBR, and cIc are equal, the level of activity is the one indicated by all parameters; 
3) If cIc indicates moderate-intensity activity and cHR vigorous-intensity activity, the activity 
intensity is classified as moderate; 
4) If each parameter points to a different activity intensity, the physical activity intensity is 
the one closest to the mean classification. 
The first rule ensures the distinction between active and inactive periods and the third is intended to 
cope with activities that cannot be fully recorded by the accelerometer. In order to calculate a mean 
classification, a numerical index was assigned to each activity level: -1 to inactivity, 0 to light, 1 to 
moderate and 2 to vigorous-intensity physical activity. The flow chart of the proposed algorithm is 
provided in Figure 4.1.  
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Figure 4.1. Flow chart of the algorithm for activity intensity classification.  
 
4.2. Algorithm for body posture recognition 
Another important aspect besides activity monitoring is body posture recognition, particularly for 
general activity assessment and during sleep. Subjects’ sleep position has been proved to have a relevant 
role in many diseases, such as benign paroxysmal positional vertigo [172] and sleep apnea [173], [174]. 
In fact, body position is one of the parameters monitored during PSG, the standard method for the 
diagnosis of sleep-related breathing disorders [174]. Furthermore, body posture is strongly associated 
with sedentary behavior, being a good indicator of how active individuals are [72].  
Accelerometry has been widely used for body posture recognition [175], [176]. The most important 
features for posture recognition based on acceleration are the orientation angles, i.e. the angles between 
the gravity vector and angles of the axes [177]. For example, tilt angle, i.e. the angle between the gravity 
vector and the z axis, is a relevant feature for activity recognition [178] and trunk inclination, i.e. the 
angle between the gravity vector and the x axis, has been used to differentiate lying, sitting and standing 
postures for sensors applied on the trunk [177]. Waist and thigh angles have also been used for posture 
recognition [179]. Apart from the sensor placement, a crucial issue when recognizing body posture 
through the use of orientation angles is to determine threshold limits, i.e. the tolerance angles, for each 
position to be identified [180]. A tolerance angle of 45° has been widely used [176], [179], [180] since 
it allows uniform distribution of body postures in terms of angular range. 
We developed an algorithm for lying position recognition based on the data recorded by the textile 
belt accelerometer. When subjects wear the textile belt, accelerometer’s x-axis points to subjects’ 
vertical direction, y-axis to the mediolateral and z-axis to the anteroposterior direction, see Figure 4.2. 
Therefore, the algorithm calculates the angle between the gravitational acceleration projection onto the 
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yz plane (transverse plane) and the y (β) and z (γ) axes (see equation 4.3) to determine subjects’ lying 
position (supine, prone, left or right).  
 
 
Figure 4.2. Axes directions of the accelerometer integrated in belt’s data logger. 
 
When the gravitational acceleration magnitude in the y (gy) and z (gz) axes are lower than 700 mg, 
the body posture is identified as not lying, i.e. standing or sitting. A tolerance angle of 45° is used for 
all positions. In order to increase the algorithm performance, the use of the inclination angles in the 
mediolateral and anteroposterior directions, i.e. the angle between the gravity vector and the y (taY) and 
z (taZ) axes (equation 4.4), respectively, was investigated. For posture recognition, only the gravitational 
acceleration is considered. For this purpose, the recorded acceleration is filtered using the elliptical filter 
described in the previous section.  
 
𝛽 (𝛾) =  
𝑔𝑦(𝑧)
√𝑔𝑦2+𝑔𝑧2
                                                              (4.3) 
 
𝑡𝑎𝑌 (𝑡𝑎𝑍) =  𝑐𝑜𝑠−1(𝑔𝑦(𝑧))                                                    (4.4) 
 
A preliminary study was conducted to test the appropriateness of the textile belt for activity 
monitoring based on the algorithms discussed here. The study is described in the following chapter. 
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5. VALIDATION STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
------------------------------------------ Content Removed ------------------------------------------ 
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6. CONCLUSION AND FUTURE WORK 
This thesis aimed to explore the use of a textile belt developed by Empa as a multi-sensor wear-
able system for long-term, remote and continuous ECG, respiratory and activity monitoring. The textile 
belt consists of a chest strap with two embroidered textile electrodes and an integrated reservoir that 
releases water vapor to moisturize the electrodes. The signals acquired by the textile electrodes are stored 
in a data logger. 
 A study involving patients with suspected sleep apnoea was conducted to explore the suitability 
of the textile belt for ECG monitoring in a home setting. Signal-to-noise ratio, baseline wander, artefact 
percentage and Poincaré plots were used to assess the quality of acquired signals. This signal quality 
assessment approach was found to be effective. Results revealed that the textile belt can acquire 1-lead 
ECG signals of good quality in a home setting. A good agreement was found between the RR-intervals 
derived from ECG recorded in home and clinical settings.  
Data from the acceleration module integrated in the belt’s data logger was used for posture 
recognition based on orientation angles. Our method achieved the accuracy required for such applica-
tions. Additionally, the proof of concept of an algorithm for physical activity intensity classification 
based on inertial acceleration, heart rate and breathing rate was presented. Preliminary results yielded 
high accuracy, showing the potential of combining those three parameters for activity monitoring.  
Additional pilot and clinical studies have to be conducted to corroborate our findings and further 
prove the clinical relevance of data acquired by the textile belt. The use of the textile belt for sleep 
assessment based on accelerometry, or apnoea detection using the signal acquired by the optical fibre-
based sensors, would ensure maximal use of the data recorded by this system. 
The current thesis supports the need for multi-sensor wearable devices for healthcare applica-
tions. The integration of sensors into a textile belt proved to be appropriate for long-term, remote and 
continuous monitoring of subjects’ physical and physiological parameters, having the potential to be 
used as tool for disease prediction and diagnose support.  
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Appendix A. ECG monitoring in a home setting  
 
Table A1. Signal quality indices of the 28 nights.  
Subject Night 
Artefact 
percentage 
SNRhf SNRlf BLW SD1 SD2 SD1/SD2 
dB dB mV ms ms ms 
112 1 1.1% 27 7 0.001 38.8 187.1 0.21 
121 2 11.3% 4 14 0.002 34.8 68.5 0.51 
121 3 7.0% 23 12 0.003 17.8 86.4 0.21 
121 4 4.0% 24 10 0.004 24.0 101.8 0.24 
129 5 2.6% 21 6 0.005 28.0 169.6 0.17 
129 6 0.9% 20 13 0.006 17.2 127.1 0.14 
129 7 1.3% 20 10 0.007 20.5 142.0 0.14 
133 8 0.2% 24 12 0.008 20.5 97.9 0.21 
133 9 0.3% 23 10 0.009 19.0 100.8 0.19 
133 10 0.3% 23 9 0.010 14.1 98.9 0.14 
155 11 1.4% 19 15 0.011 34.4 157.3 0.22 
160 12 47.8% 26 8 0.012 82.5 227.5 0.36 
160 13 27.4% 23 9 0.013 50.8 156.2 0.33 
161 14 0.2% 21 13 0.014 15.5 97.9 0.16 
161 15 0.3% 17 11 0.015 13.9 95.2 0.15 
161 16 0.2% 21 12 0.016 17.2 85.5 0.20 
166 17 0.6% 17 9 0.017 11.4 74.5 0.15 
166 18 6.2% 16 11 0.018 26.9 80.6 0.33 
166 19 5.0% 15 11 0.019 16.4 105.5 0.16 
168 20 0.6% 24 10 0.020 26.9 176.4 0.15 
168 21 0.6% 24 13 0.021 26.3 181.7 0.15 
168 22 0.9% 24 11 0.022 31.4 151.7 0.21 
186 23 12.2% 26 12 0.023 80.0 179.3 0.45 
206 24 7.3% 18 9 0.024 22.1 129.2 0.17 
206 25 6.2% 20 11 0.025 33.4 119.9 0.28 
206 26 10.3% 20 12 0.026 32.8 127.3 0.26 
228 27 15.1% 26 9 0.027 53.7 192.8 0.28 
228 28 15.8% 25 9 0.028 53.6 132.1 0.41 
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Figure A1. Poincaré plot of subject 112. Data acquired by the gel electrodes during the clinical study (left), and data acquired 
in the home setting (right). 
 
 
Figure A2. Poincaré plot of subject 121. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
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Figure A3. Poincaré plot of subject 129. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
 
 
Figure A4. Poincaré plot of subject 133. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
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Figure A5. Poincaré plot of subject 155. Data acquired by the gel electrodes during the clinical study (left), and data acquired 
in the home setting (right). 
 
 
 
Figure A6. Poincaré plot of subject 160. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
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Figure A7. Poincaré plot of subject 161. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
 
 
Figure A8. Poincaré plot of subject 166. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
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Figure A9. Poincaré plot of subject 168. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
 
 
Figure A10. Poincaré plot of subject 186. Data acquired by the gel electrodes during the clinical study (left), and data acquired 
in the home setting (right).  
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Figure A11. Poincaré plot of subject 206. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
 
 
Figure A12. Poincaré plot of subject 228. Data acquired by the gel electrodes during the clinical study (top, left), and data 
acquired in the home setting (remainder). 
